Primary tumor resection of non‐small cell lung cancer patients with ipsilateral pleural dissemination (M1a) in the era of targeted therapy
Abstract Background Non‐small cell lung cancer (NSCLC) patients with ipsilateral pleural dissemination (M1a) are generally contraindicated for surgery. Recently, several studies have demonstrated that these patients might benefit from primary tumor resection (PTR). However, whether PTR is beneficial...
Main Authors: | Hao Li, Taorui Liu, Zewen Sun, Fan Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.13649 |
Similar Items
-
Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination
by: Zhenfan Wang, et al.
Published: (2021-07-01) -
Pleural cryobiopsy during local anaesthetic thoracoscopy in dry pleural dissemination
by: Ayn Marie Lao, et al.
Published: (2020-01-01) -
Pleural staging using local anesthetic thoracoscopy in dry pleural dissemination and minimal pleural effusion
by: Tatsuya Imabayashi, et al.
Published: (2021-04-01) -
MSCT Imaging Diagnosis of Peripheral Lung Cancer with Dry Pleural Dissemination
by: Jia LIU, et al.
Published: (2014-05-01) -
Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
by: Liwen Fan, et al.
Published: (2021-06-01)